Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 5.08% vs 5.84% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 111.29% vs -36.66% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 168.50% vs -350.46% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 33.33% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Ligand Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 5.08% vs 5.84% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 14.70% vs 57.20% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 111.29% vs -36.66% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 109.25% vs -2,356.52% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 168.50% vs -350.46% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 11.98% vs 122.67% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 33.33% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -7.69% vs 333.33% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






